Healthcare & Life Sciences
Nautilus Biotechnology
United Stateswww.nautilus.bio
Nautilus Biotechnology is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 3 tracked investors.
Activeseries-b
series-b
Stage
2017
Founded
3
Investors
About Nautilus Biotechnology
Based in the United States, Nautilus Biotechnology is a startup founded in 2017. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Nautilus Biotechnology develops a single-molecule proteomics platform and laboratory instruments to sequence and quantify proteins at large scale, enabling high-throughput protein analysis for research and diagnostic applications.
Explore Nautilus Biotechnology's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.